Results 171 to 180 of about 48,974 (212)
Some of the next articles are maybe not open access.
Docetaxel induction combination for HNSCC
The Lancet Oncology, 2007Addition of docetaxel to cisplatin and fl uorouracil in locally advanced unresectable head and neck squamous cell cancer (HNSCC) imp roves progressionfree survival (N Engl J Med 2007; 357: 1695–704) and overall survival (N Engl J Med 2007; 357: 1705–15).
openaire +2 more sources
2023
Abstract Background The study of molecular markers for diagnosis and prognosis is of great clinical significance for HNSCC patients. In this study, we proposed that FSCN1 has a potential indication for prognosis and is essential for the migration of HNSCC.
openaire +1 more source
Abstract Background The study of molecular markers for diagnosis and prognosis is of great clinical significance for HNSCC patients. In this study, we proposed that FSCN1 has a potential indication for prognosis and is essential for the migration of HNSCC.
openaire +1 more source
Impact of AIM2 on HNSCC Development
Abstract Head and neck squamous cell carcinoma (HNSCC) constitutes 90% of head and neck cancers. HNSCC development is linked to chronic inflammation, while established HNSCC tumors are often immune suppressive. However, both occur through mechanisms that are not fully understood.Dakota M. Reinartz +4 more
openaire +2 more sources
Otolaryngology–Head and Neck Surgery, 2008
ProblemDown regulation of E‐cadherin is the hallmark of epithelial mesenchymal transition (EMT). The loss of E‐cadherin confers a more invasive phenotype and is one of the steps leading to metastasis. Our recent investigations indicate that inflammatory mediators are potent regulators of EMT in HNSCC.MethodsImmunohistochemical analysis of HNSCC tumor ...
openaire +1 more source
ProblemDown regulation of E‐cadherin is the hallmark of epithelial mesenchymal transition (EMT). The loss of E‐cadherin confers a more invasive phenotype and is one of the steps leading to metastasis. Our recent investigations indicate that inflammatory mediators are potent regulators of EMT in HNSCC.MethodsImmunohistochemical analysis of HNSCC tumor ...
openaire +1 more source
Human Papillomavirus in HNSCC: A European Epidemiologic Perspective
Hematology/Oncology Clinics of North America, 2008The aim of this study was to assess incidence and survival of human papillomavirus-related and unrelated head and neck squamous cell carcinoma sites from 15 European population-based cancer registries. This analysis was performed on 29,265 adult (aged approximately 15 years) cancer patients diagnosed in the period from 1988 to 2002.
L. Licitra +4 more
openaire +2 more sources
Molecular Modeling of Diagnosis in HNSCC
Otolaryngology–Head and Neck Surgery, 2004Problem: A current shortcoming in the prognosis and treatment of head and neck squamous cell carcinoma (HNSCC) is a lack of methods that adequately address the complexity and diversity of the disease. Molecular modeling to assess the predictive ability of an evidence-based panel of gene loci implicated in head and neck cancer to differentiate early ...
Maria J Worsham +4 more
openaire +1 more source
Predictive Factors for Posterior Triangle Metastasis in HNSCC
The Laryngoscope, 2005AbstractObjective: Surgical modifications sparing uninvolved structures such as the spinal accessory nerve have been implemented since the advent of the radical neck dissection in 1906. The increased morbidity to the spinal accessory nerve involved with the dissection of level V lymph nodes has led to much controversy.
Chad M, McDuffie +5 more
openaire +2 more sources
Im Focus Onkologie, 2018
Inwieweit konnen Antikorper gegen den epidermalen Wachstumsfaktorrezeptor (EGFR) das Ergebnis beim Plattenepithelkarzinom des Kopf- und Halsbereichs (HNSCC) verbessern?
openaire +1 more source
Inwieweit konnen Antikorper gegen den epidermalen Wachstumsfaktorrezeptor (EGFR) das Ergebnis beim Plattenepithelkarzinom des Kopf- und Halsbereichs (HNSCC) verbessern?
openaire +1 more source